Australian Pharmacist

Thom, 37, a regular patient of the pharmacy, presents their venlafaxine repeat for dispensing. You know this has been prescribed for PTSD and ask how they have been going with their treatment. They disclose that their symptoms have been difficult to manage over the last few weeks and that they don’t feel like their medication has been working as well. Thom explains that a friend mentioned MDMA could be used for PTSD, and they’re now considering taking it to help them feel better.

The most-read stories of the year highlight where clinical practice, regulation and professional reform collided. From sweeping Therapeutic Guidelines updates to unresolved scheduling decisions and...

Western Australian pharmacists were treated to a program chock-full of clinical advice for grappling with some of today’s key health issues at PSA’s 2021 WA Annual Therapeutic Update held on 8 May.

Between mid-March and late April last year, the Pharmacists’ Support Service received a massive 88% increase in calls from distressed pharmacists compared with the same period in 2019,

Thalidomide’s period of use may have been short but its ramifications have lasted decades, both for people who suffer deformities from its effects and...

Research highlights the vital role HMRs play in averting medicine misadventure. In 2016, members of the PSA Accredited Pharmacist Leadership Group (APLG) undertook an...